The company generated 221.3 billion won in operating profit for the first three months of the year, up 15 percent on year. It ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March ...

there were one or more issues with the Company's third-party contract manufacturing organization ("CMO") for cosibelimab; (iii) all the foregoing reduced the likelihood that the FDA would approve the ...

there were one or more issues with the Company’s third-party contract manufacturing organization (“CMO”) for cosibelimab; (iii) all the foregoing reduced the likelihood that the FDA would approve the ...

The Active Pharmaceutical Ingredient Market sits at the heart of the global pharmaceutical industry. APIs are the essential, ...

there were one or more issues with the Company's third-party contract manufacturing organization ("CMO") for cosibelimab; (3) all the foregoing reduced the likelihood that the FDA would approve the ...

NDAQ:CKPT) Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Checkpoint Therapeutics, Inc. (CKPT) ...

Teams across Zealand will use the Benchling R&D Cloud to capture, analyze, and share stability data internally and with their external contract manufacturing organization (CMO) partners, in compliance ...

Good day and welcome to the Community Health Systems' first-quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the ...

The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, ...

Q4 2023 Earnings Call April 24, 2024 CureVac N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to ...

Thank you, Chuck. Good morning, everyone and welcome to Community Health Systems’ first quarter 2024 conference call. Joining me on today’s call are Tim Hingtgen, Chief Executive Officer; Kevin ...